Safety of ambroxol in the treatment of airway diseases in adult patients-Reference-Cited by-同舟云学术

Safety of ambroxol in the treatment of airway diseases in adult patients

Published:2018-11-22 Issue:12 Volume:17 Page:1211-1224
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Cazan Dorotheea¹,Klimek Ludger²,Sperl Annette²,Plomer Manuel³,Kölsch Stephan³

Affiliation:

1. Department of Otorhinolaryngology, Head and Neck Surgery, Sleep Disorders Center, University Hospital Mannheim, Mannheim, Germany

2. Wiesbaden Center for Rhinology and Allergology, Wiesbaden, Germany

3. Global Medical Affairs, Sanofi Aventis Deutschland GmbH, Frankfurt am Main, Germany

Funder

Sanofi-Aventis

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2018.1533954

Reference55 articles.

1. A Controlled Trial of Ambroxol in Chronic Bronchitis

2. European Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee (PRAC). Revised assessment report: ambroxol and bromhexine containing medicinal products. 2015. [cited 2018 Sept 09]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Ambroxol_and_bromhexine_31/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500184106.pdf.

3. Activity of bromhexine and ambroxol, semi-synthetic derivatives of vasicine from the Indian shrub Adhatoda vasica, against Mycobacterium tuberculosis in vitro

4. Ambroxol - Resurgence of an old molecule as an anti-inflammatory agent in chronic obstructive airway diseases

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ambroxol hydrochloride spray (Luo Runchang®) in the treatment of acute respiratory infectious diseases: a prospective, multicenter, open label, randomized controlled study;Frontiers in Pediatrics;2024-09-05

2. Molecular mechanisms of the ambroxol action in Gaucher disease and GBA1 mutation-associated Parkinson disease;Neurochemistry International;2024-09

3. Exploring the efficacy and safety of Ambroxol in Gaucher disease: an overview of clinical studies;Frontiers in Pharmacology;2024-02-13

4. The evaluation of the protective effect of ambroxol against acetaminophen-induced hepatorenal toxicity in rats;Journal of Research in Pharmacy;2024

5. Acute generalized exanthematous pustulosis induced by Ambroxol confirmed by positive skin tests;Contact Dermatitis;2023-11